Image tracing

Adobe Firefly Now Powers First Groundbreaking Generative AI Capabilities in Adobe Illustrator

Retrieved on: 
Tuesday, June 13, 2023

Today, at MAX London, Adobe (Nasdaq:ADBE) unveiled Generative Recolor (beta), the first integration of Adobe Firefly in Adobe Illustrator , enabling designers to quickly experiment with colors using simple text prompts.

Key Points: 
  • Today, at MAX London, Adobe (Nasdaq:ADBE) unveiled Generative Recolor (beta), the first integration of Adobe Firefly in Adobe Illustrator , enabling designers to quickly experiment with colors using simple text prompts.
  • Adobe has pioneered numerous AI innovations for more than a decade, introducing hundreds of Adobe Sensei intelligent features across Creative Cloud , Document Cloud and Experience Cloud .
  • “Adobe Illustrator is the tool behind many of the world’s most iconic designs, from brand logos to product packaging,” said Ashley Still, senior vice president, digital media at Adobe.
  • Generative Recolor and Retype are available as beta features in Illustrator today, along with enhancements to Layers and Image Trace.

Paperless Parts Introduces Ability to Extract and Annotate PDF Data for Improved Quoting

Retrieved on: 
Tuesday, January 12, 2021

Paperless Parts new feature lets customers use those same PDF files and the data within them in new, more valuable ways.

Key Points: 
  • Paperless Parts new feature lets customers use those same PDF files and the data within them in new, more valuable ways.
  • In addition, Vectorization and Analysis capabilities turn a PDF into a Drawing Interexchange Format (DXF) to extract complete data, improving estimating accuracy and preventing return materials authorizations.
  • Now, these multiple steps can all be done with Paperless Parts, said Rob Faraci, Value Add Process Manager at thyssenkrupp Materials NA .
  • Paperless Parts is the leading secure, ITAR compliant cloud-based sales and quoting platform that is revolutionizing manufacturing.

Factor Bioscience Granted Second U.S. Patent for mRNA Vectorization of TALENs Technology

Retrieved on: 
Tuesday, November 10, 2020

CAMBRIDGE, Mass., Nov. 10, 2020 /PRNewswire/ --Factor Bioscience Inc., a Cambridge-based biotechnology company that develops cell-engineering technologies, today announced that the United States Patent and Trademark Office has granted Factor Bioscience U.S. Patent No.

Key Points: 
  • CAMBRIDGE, Mass., Nov. 10, 2020 /PRNewswire/ --Factor Bioscience Inc., a Cambridge-based biotechnology company that develops cell-engineering technologies, today announced that the United States Patent and Trademark Office has granted Factor Bioscience U.S. Patent No.
  • This patent is the second Factor has been granted for the mRNA vectorization of TALENs in 2020.
  • This is the second patent that Factor has been granted for the mRNA vectorization of TALENs in 2020.
  • "This second patent covering mRNA vectorization of TALENs provides additional protectionand underscores Factor's contribution to the development of clinically useful gene-editing technologies," said co-inventor Matt Angel, Ph.D., Co-Founder, Chairman, and CEO.